v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating Activities    
Net Loss $ (7,718,007) $ (6,125,570)
Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities:    
Depreciation And Amortization 224,310 227,342
Amortization Of Operating Lease Right-of-use Assets 65,361 50,046
Stock-based Compensation 915,031 555,342
Changes In Operating Assets And Liabilities:    
Prepaid Expenses (664,782) (792,793)
Accounts Receivable (59,861) (14,238)
Other Current Assets (102,185) 86,907
Deferred Revenue, Current And Non-current 10,000,000 0
Accounts Payable And Accrued Liabilities 361,237 (87,002)
Management And Directors' Fees Payable 25,750 (15,690)
Right-of-use Assets Operating Leases Liabilities (57,008) (49,485)
Net Cash Provided By / (used In) Operating Activities 2,989,846 (6,165,141)
Investing Activities:    
Purchases Of Property And Equipment (124,648) (483,940)
Net Cash Used In Investing Activities (124,648) (483,940)
Financing Activities:    
Net Proceeds From Issuances Of Common Stock 9,467 20,328,928
Tax Withholdings Paid Related To Stock-based Compensation 0 (23,758)
Proceeds From Long-term Debt 620,549 79,590
Payments On Long-term Debt (250,711) (161,727)
Payments On Finance Lease Obligations (13,133) (14,722)
Net Cash Provided By Financing Activities 366,172 20,208,311
Effect Of Foreign Exchange On Cash (80,304) 57,744
Net Change In Cash 3,151,066 13,616,974
Cash And Cash Equivalents - Beginning Of Period 20,581,313 19,444,737
Cash And Cash Equivalents - End Of Period 23,732,379 33,061,711
Supplemental Disclosures Of Cash Flow Information:    
Interest Paid $ 41,032 $ 42,181
Non-cash Financing Activities:    
Common Stock Issued On Cashless Exercises Of Stock Options And Settlement Of Vested Rsus 15 80
Offering Costs From Issuance Of Common Stock $ 0 $ 119,029

Source